Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 41-50 of 272 for

Edit search filters
  1. A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-Administration of ABT-493 and ABT-530 With and Without RBV in Subjects With Chronic Hepatitis C Virus (HCV) Genotypes 2, 3, 4, 5 or 6 Infection

    Scottsdale/Phoenix, AZ

  2. A Study of Clofazimine for Treating Patients with Drug Resistant Non-Tuberculous Mycobacterial Infections

    Rochester, MN

  3. A Study to Evaluate Fisetin to Alleviate Dysfunction and Inflammation in COVID-19 Subjects

    Rochester, MN

  4. A Study to Evaluate the Effectiveness of Merimepodib in Adult Patients with Advanced COVID-1

    Scottsdale/Phoenix, AZ, Rochester, MN, Jacksonville, FL

  5. A Study to Evaluate Rivaroxaban to Reduce Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients with Acute COVID-19 Infection

    Rochester, MN

  6. ECOSPOR IV: An Open-Label Extension of Study SERES 0012 Evaluating SER-109 in Subjects With Recurrent Clostridium Difficile Infection

    Rochester, MN

  7. A Study of the Effect of Ixazomib on the Reservoir of T Cells Infected with HIV DNA

    Rochester, MN

  8. Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)

    Rochester, MN

  9. Study of INTERCEPT Blood System for Red Blood Cells in Regions at Potential Risk for Zika Virus Transfusion-Transmitted Infections (RedeS)

    Jacksonville, FL

  10. A Study to Evaluate MesilatE for Treating Hospitalized Patients with COVID-19 (Enrolling by Invitation Only)

    Jacksonville, FL

.

Mayo Clinic Footer